ClinicalTrials.Veeva

Menu

Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota

University of California (UC) Davis logo

University of California (UC) Davis

Status

Completed

Conditions

Changes in the Oral Microbiota

Treatments

Other: Colostrum

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Oropharyngeal administration of mother's colostrum to premature infants has been proposed as a stimulus to the oropharyngeal lymphatic tissues to decrease the incidence of pneumonia and sepsis, particularly in intubated babies. We propose to study the impact of this intervention on the composition of the oral microbiota.

Enrollment

12 patients

Sex

All

Ages

12 hours to 7 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • premature infant with birth weight < 1500
  • intubated in the first 48 hours of life
  • available maternal colostrum

Exclusion criteria

  • lethal condition

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

12 participants in 2 patient groups

Colostrum
Experimental group
Description:
Colostrum administration
Treatment:
Other: Colostrum
Control
No Intervention group
Description:
Routine care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems